Bank Of New York Mellon Corp Cin Cor Pharma, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.75 - $29.84 $812,936 - $2.26 Million	75,622 New	75,622 $929,000
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $757,533 - $1.48 Million	38,067 Added 109.4%	72,863 $2.39 Million
Q2 2022 Aug 15, 2022	BUY	$13.67 - $25.74 $35,350 - $66,563	2,586 Added 8.03%	34,796 $655,000
Q1 2022 May 11, 2022	BUY	$14.13 - $28.49 $455,127 - $917,662	32,210 New	32,210 $565,000

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.